Jazz Pharmaceuticals plc (JAZZ)
USD 121.74
(-0.61%)
USD 121.74
(-0.61%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.09 Billion | 1.27 Billion | 778.5 Million | 899.64 Million | 776.4 Million | 798.9 Million |
| Net Income | 414.83 Million | -224.06 Million | -329.66 Million | 238.61 Million | 523.36 Million | 447.09 Million |
| Depreciation & Amortization | 638.69 Million | 629.47 Million | 552.48 Million | 278.25 Million | 370.15 Million | 216.73 Million |
| Deferred income taxes | -260.21 Million | -292.25 Million | 69.19 Million | -136.93 Million | -236.61 Million | -88.81 Million |
| Stock-based compensation | 226.84 Million | 221.99 Million | 189 Million | 120.99 Million | 110.56 Million | 102.44 Million |
| Change in working capital | -204.43 Million | 9.9 Million | -47.95 Million | -85.43 Million | -150.08 Million | 23.28 Million |
| Other non-cash items | 276.29 Million | 926.91 Million | 345.44 Million | 484.15 Million | 159 Million | 98.16 Million |
| Investing Cash Flow | -163.06 Million | -446.23 Million | -5.21 Billion | -1 Billion | -155.3 Million | -394.48 Million |
| Investments in PPE | -23.96 Million | -498.19 Million | -45.53 Million | -379.25 Million | -182.33 Million | -131.47 Million |
| Acquisitions | - | 53 Million | -6.23 Billion | -364.25 Million | -142.2 Million | 111.1 Million |
| Investment purchases | -390.1 Million | -61.03 Million | -26.81 Million | -2.39 Billion | -917.1 Million | -1.16 Billion |
| Sales/Maturities of investments | 270 Million | 60 Million | 1.09 Billion | 1.75 Billion | 985 Million | 855 Million |
| Other Investing Activities | -19 Million | -444.14 Million | 1.05 Billion | 378.5 Million | 101.33 Million | -63.2 Million |
| Financing Cash Flow | -305.25 Million | -529.49 Million | 3.97 Billion | 528.07 Million | -293.74 Million | -479.13 Million |
| Debt repayment | -31 Million | -582.01 Million | -1.32 Billion | -889.57 Million | -33.38 Million | -25.71 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -269.76 Million | -54 Thousand | -35.6 Million | -146.53 Million | -301.45 Million | -523.67 Million |
| Common Stock Issuance | 46.45 Million | 98.02 Million | 135.26 Million | 99.68 Million | 57.83 Million | 93.33 Million |
| Other Financing Activities | -50.95 Million | 52.57 Million | 5.29 Billion | 1.56 Billion | 41.09 Million | 70.25 Million |
| Accounts receivables | -51.88 Million | -90.13 Million | -92.73 Million | -38.64 Million | -92.32 Million | -40.13 Million |
| Accounts payables | 9.6 Million | -11.22 Million | 57.02 Million | -18.93 Million | 4.77 Million | 17.04 Million |
| Inventory | -13.42 Million | -49.64 Million | -48.86 Million | -30.53 Million | -32.79 Million | -18.51 Million |
| Other working capital | -148.73 Million | 160.9 Million | 36.62 Million | 2.68 Million | -29.73 Million | 64.89 Million |
| Cash at beginning of period | 851.48 Million | 591.44 Million | 1.05 Billion | 637.34 Million | 309.62 Million | 386.03 Million |
| Cash at end of period | 1.2 Billion | 881.48 Million | 591.44 Million | 1.05 Billion | 637.34 Million | 309.62 Million |
| Capital Expenditure | -23.96 Million | -498.19 Million | -45.53 Million | -379.25 Million | -182.33 Million | -131.47 Million |
| Effect of forex changes on cash | 1.13 Million | -6.22 Million | -3.2 Million | 374 Thousand | 366 Thousand | -1.7 Million |
| Net cash flow / Change in cash | 354.82 Million | 290.03 Million | -466.32 Million | 420.42 Million | 327.72 Million | -76.41 Million |
| Free Cash Flow | 1.06 Billion | 773.78 Million | 732.97 Million | 520.39 Million | 594.06 Million | 667.43 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 168.56 Million | -14.61 Million | 414.83 Million | 94.15 Million | 146.82 Million | 104.43 Million |
| Depreciation & Amortization | 163.03 Million | 163.38 Million | 638.69 Million | 159.2 Million | 162.55 Million | 159.57 Million |
| Deferred income taxes | -75.18 Million | -66.38 Million | -260.21 Million | -35.9 Million | -78.92 Million | -79.33 Million |
| Stock-based compensation | 56.65 Million | 61.44 Million | 226.84 Million | 52.94 Million | 56.11 Million | 61.43 Million |
| Change in working capital | -26.8 Million | 56.4 Million | -204.43 Million | -181 Million | -24.54 Million | -17.2 Million |
| Other non-cash items | 408.38 Million | 496.09 Million | 276.29 Million | 77.95 Million | 45.17 Million | 67.85 Million |
| Investing Cash Flow | -257.09 Million | -271.9 Million | -163.06 Million | 101.79 Million | -174.29 Million | -85.73 Million |
| Investments in PPE | -7.09 Million | -6.9 Million | -23.96 Million | -10.1 Million | -4.29 Million | -5.73 Million |
| Acquisitions | - | - | - | 20 Million | -20 Million | - |
| Investment purchases | -330 Million | -375 Million | -390.1 Million | -120.1 Million | -190 Million | -80 Million |
| Sales/Maturities of investments | 80 Million | 120 Million | 270 Million | 250 Million | 20 Million | - |
| Other Investing Activities | -250 Million | -10 Million | -19 Million | -18 Million | 20 Million | -80 Million |
| Financing Cash Flow | -161.08 Million | -56.55 Million | -305.25 Million | -100.3 Million | -78.49 Million | -96.66 Million |
| Debt repayment | -7.75 Million | -7.75 Million | -31 Million | -7.75 Million | -7.75 Million | -7.75 Million |
| Dividends payments | - | - | - | -112.27 Million | - | - |
| Common Stock Repurchased | -161.42 Million | -49.29 Million | -269.76 Million | -99.79 Million | -74.37 Million | -95.59 Million |
| Common Stock Issuance | 10.94 Million | 494 Thousand | 46.45 Million | 8.85 Million | 5.51 Million | 10.86 Million |
| Other Financing Activities | -2.84 Million | -49.29 Million | -50.95 Million | -1.61 Million | 3.62 Million | 80.54 Million |
| Accounts receivables | 8.72 Million | -8.44 Million | -51.88 Million | -75.46 Million | -18.85 Million | 13.97 Million |
| Accounts payables | 15.44 Million | -19.59 Million | 9.6 Million | -8.1 Million | 10.24 Million | -26.82 Million |
| Inventory | -4.74 Million | -12.84 Million | -13.42 Million | -1.4 Million | -4.93 Million | -816 Thousand |
| Other working capital | -46.22 Million | 97.28 Million | -148.73 Million | -96.03 Million | -10.99 Million | -3.54 Million |
| Cash at beginning of period | 1.23 Billion | 1.2 Billion | 851.48 Million | 1.02 Billion | 1.28 Billion | 1.16 Billion |
| Cash at end of period | 1.29 Billion | 1.23 Billion | 1.2 Billion | 1.2 Billion | 1.33 Billion | 1.28 Billion |
| Capital Expenditure | -7.09 Million | -6.9 Million | -23.96 Million | -10.1 Million | -4.29 Million | -5.73 Million |
| Effect of forex changes on cash | -759 Thousand | -1.69 Million | 1.13 Million | 1.78 Million | -1.01 Million | 34 Thousand |
| Net cash flow / Change in cash | 62.41 Million | 27.07 Million | 354.82 Million | 180.62 Million | 53.38 Million | 114.39 Million |
| Free Cash Flow | 324.26 Million | 260.32 Million | 1.06 Billion | 157.23 Million | 302.89 Million | 291.02 Million |
600376
CRN
3234
SUHJY
CPWHF
3647